University of California, San Francisco: Immunologic Deficiency Syndromes trials
The registry lists 12 Immunologic Deficiency Syndromes studies with University of California, San Francisco as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 1 2Phase 2 3Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenCompletedNCT04772469Not applicableResults posted
- Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)CompletedNCT02282293Phase 3Results posted
- Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & FilgrastimTerminatedNCT01182675Phase 2Results posted
- Mesalamine to Reduce T Cell Activation in HIV InfectionCompletedNCT01090102Phase 4Results posted
- Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsCompletedNCT03609840
- Sirolimus Prophylaxis for aGVHD in TME SCIDWithdrawnNCT02177760Phase 2
- Primary Care-Based Interventions to Reduce Alcohol Use Among HIV PatientsCompletedNCT01671501Not applicable
- Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)CompletedNCT01227590Phase 1
- Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk PopulationCompletedNCT00845416
- Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From PrisonCompletedNCT00344591Phase 2
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- The Efficacy of the HIV/AIDS Symptom Management ManualCompletedNCT00241202Not applicable